NK.IO LIMITED

EC2N 1HQ (London)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£300,000

Mar 21 - Jul 22

Novel small molecule enhanced NK cell immunotherapy

Innovate UK award to NK.IO LIMITED and Andrew Baxendale

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}